Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Autofluorescence of NADH is a new biomarker for sorting and characterizing cancer stem cells in human glioma

Fig. 3

NADHhigh glioma cells exhibit characteristics of cancer stem cells in vivo. a Bioluminescent images and quantification showed that the total flux of the tumors derived from NADHhigh LN229 cells (left flank) was extremely higher than that of the tumors derived from NADHlow LN229 cells (right flank) at 28 days after subcutaneous implantation in NOD/SCID mice. Also, the total photon flux of the tumors was increased with implanted cell number. Signal intensity is represented as p/s/cm2/sr. b The images of xenograft tumors showed that NADHhigh LN229 cells had higher rate of tumor formation than NADHlow cells (left panel). Weight statistical diagram showed that the weight of NADHhigh LN229 cell-derived tumors was heavier than that of NADHlow LN229 cell-derived tumors (right panel). c H&E staining confirmed the glioma origin of the xenograft tumors, and IHC staining showed that NADHhigh LN229 cell-derived tumors expressed higher expression of Sox2 and Ki67 than NADHlow cells. Scale bar = 50 μm. All data are presented as the means ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 (n = 3 independent experiments)

Back to article page